PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 137 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,672,440 | +28.5% | 153,294 | -0.8% | 0.02% | +13.6% |
| Q3 2022 | $1,302,000 | -55.2% | 154,482 | -57.9% | 0.02% | -51.1% |
| Q2 2022 | $2,904,000 | -67.7% | 367,117 | -3.2% | 0.04% | -60.9% |
| Q1 2022 | $8,978,000 | -46.5% | 379,126 | -22.8% | 0.12% | -41.6% |
| Q4 2021 | $16,793,000 | +335.7% | 491,024 | +125.8% | 0.20% | +310.4% |
| Q3 2021 | $3,854,000 | -77.9% | 217,483 | -44.0% | 0.05% | -76.8% |
| Q2 2021 | $17,424,000 | +54.9% | 388,228 | -10.6% | 0.21% | +48.9% |
| Q1 2021 | $11,247,000 | – | 434,249 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $43,400,000 | 3.81% |
| BVF INC/IL | 3,901,759 | $69,139,000 | 2.70% |
| COMMODORE CAPITAL LP | 498,079 | $8,826,000 | 2.33% |
| Altium Capital Management LP | 346,000 | $6,131,000 | 1.61% |
| Twin Lakes Capital Management, LLC | 139,287 | $2,468,000 | 1.45% |
| Opaleye Management Inc. | 330,222 | $5,852,000 | 1.09% |
| EcoR1 Capital, LLC | 1,443,800 | $25,584,000 | 0.89% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 776,689 | $13,763,000 | 0.76% |
| JABODON PT CO | 90,656 | $1,606,000 | 0.66% |
| Artal Group S.A. | 1,500,000 | $26,580,000 | 0.60% |